Format
Sort by
Items per page

Send to

Choose Destination

Best matches for galectin-3 AND ulcer OR galectin-3 AND gastric OR galectin-3 AND intestinal:

Search results

Items: 1 to 20 of 85

1.

Desmoglein 2, but not desmocollin 2, protects intestinal epithelia from injury.

Gross A, Pack LAP, Schacht GM, Kant S, Ungewiss H, Meir M, Schlegel N, Preisinger C, Boor P, Guldiken N, Krusche CA, Sellge G, Trautwein C, Waschke J, Heuser A, Leube RE, Strnad P.

Mucosal Immunol. 2018 Nov;11(6):1630-1639. doi: 10.1038/s41385-018-0062-z. Epub 2018 Aug 16.

PMID:
30115995
2.

Molecular basis for intestinal mucin recognition by galectin-3 and C-type lectins.

Leclaire C, Lecointe K, Gunning PA, Tribolo S, Kavanaugh DW, Wittmann A, Latousakis D, MacKenzie DA, Kawasaki N, Juge N.

FASEB J. 2018 Jun;32(6):3301-3320. doi: 10.1096/fj.201700619R. Epub 2018 Jan 29.

3.

Current and future pharmacological therapies for NAFLD/NASH.

Sumida Y, Yoneda M.

J Gastroenterol. 2018 Mar;53(3):362-376. doi: 10.1007/s00535-017-1415-1. Epub 2017 Dec 16. Review.

4.

Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors.

Ajani JA, Estrella JS, Chen Q, Correa AM, Ma L, Scott AW, Jin J, Liu B, Xie M, Sudo K, Shiozaki H, Badgwell B, Weston B, Lee JH, Bhutani MS, Onodera H, Suzuki K, Suzuki A, Ding S, Hofstetter WL, Johnson RL, Bresalier RS, Song S.

Br J Cancer. 2018 Jan;118(1):52-61. doi: 10.1038/bjc.2017.388. Epub 2017 Nov 14.

PMID:
29136404
5.

Galectin-3 Expression in Colorectal Cancer and its Correlation with Clinical Pathological Characteristics and Prognosis.

Tao L, Jin L, Dechun L, Hongqiang Y, Changhua K, Guijun L.

Open Med (Wars). 2017 Jul 13;12:226-230. doi: 10.1515/med-2017-0032. eCollection 2017.

6.

Use of Atomic Force Microscopy to Study the Multi-Modular Interaction of Bacterial Adhesins to Mucins.

Gunning AP, Kavanaugh D, Thursby E, Etzold S, MacKenzie DA, Juge N.

Int J Mol Sci. 2016 Nov 8;17(11). pii: E1854.

7.

Playing Modular Puzzle with Adhesion/Growth-Regulatory Galectins: Design and Testing of a Hybrid to Unravel Structure-Activity Relationships.

Ludwig AK, Vértesy S, Michalak M, Manning JC, Andre S, Kubler D, Kopitz J, Kaltner H, Gabius HJ.

Protein Pept Lett. 2016;23(11):1003-1012.

PMID:
27697034
8.

Galectin-3 causes enteric neuronal loss in mice after left sided permanent middle cerebral artery occlusion, a model of stroke.

Cheng X, Boza-Serrano A, Turesson MF, Deierborg T, Ekblad E, Voss U.

Sci Rep. 2016 Sep 9;6:32893. doi: 10.1038/srep32893.

9.
10.

Liver Fibrosis: From Pathogenesis to Novel Therapies.

Weiskirchen R, Tacke F.

Dig Dis. 2016;34(4):410-22. doi: 10.1159/000444556. Epub 2016 May 11.

PMID:
27170396
11.

A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders.

Papa Gobbi R, De Francesco N, Bondar C, Muglia C, Chirdo F, Rumbo M, Rocca A, Toscano MA, Sambuelli A, Rabinovich GA, Docena GH.

Biofactors. 2016 Jan-Feb;42(1):93-105. doi: 10.1002/biof.1252. Epub 2016 Feb 1.

PMID:
26891020
12.

Immunohistochemical Studies on Galectin Expression in Colectomised Patients with Ulcerative Colitis.

Block M, Mölne J, Leffler H, Börjesson L, Breimer ME.

Biomed Res Int. 2016;2016:5989128. doi: 10.1155/2016/5989128. Epub 2016 Jan 18.

13.

Galectin-3 Plays an Important Pro-inflammatory Role in the Induction Phase of Acute Colitis by Promoting Activation of NLRP3 Inflammasome and Production of IL-1β in Macrophages.

Simovic Markovic B, Nikolic A, Gazdic M, Bojic S, Vucicevic L, Kosic M, Mitrovic S, Milosavljevic M, Besra G, Trajkovic V, Arsenijevic N, Lukic ML, Volarevic V.

J Crohns Colitis. 2016 May;10(5):593-606. doi: 10.1093/ecco-jcc/jjw013. Epub 2016 Jan 19.

14.

Differential proteome analysis along jejunal crypt-villus axis in piglets.

Xiong X, Yang H, Hu X, Wang X, Li B, Long L, Li T, Wang J, Hou Y, Wu G, Yin Y.

Front Biosci (Landmark Ed). 2016 Jan 1;21:343-63.

PMID:
26709777
15.

Galectin-3 suppresses mucosal inflammation and reduces disease severity in experimental colitis.

Tsai HF, Wu CS, Chen YL, Liao HJ, Chyuan IT, Hsu PN.

J Mol Med (Berl). 2016 May;94(5):545-56. doi: 10.1007/s00109-015-1368-x. Epub 2015 Dec 2.

PMID:
26631140
16.

Chemoprevention of Azoxymethane-induced Colonic Carcinogenesis in Balb/c mice Using a Modified Pectin Alginate Probiotic.

Odun-Ayo F, Mellem J, Naicker T, Reddy L.

Anticancer Res. 2015 Sep;35(9):4765-75.

PMID:
26254367
17.

Galectin-3 Modulates Experimental Colitis.

Lippert E, Stieber-Gunckel M, Dunger N, Falk W, Obermeier F, Kunst C.

Digestion. 2015;92(1):45-53. doi: 10.1159/000431312. Epub 2015 Jul 17.

PMID:
26202676
18.

Role of galectins in re-epithelialization of wounds.

Panjwani N.

Ann Transl Med. 2014 Sep;2(9):89. doi: 10.3978/j.issn.2305-5839.2014.09.09. Review.

19.

Increased expression of colonic Wnt9A through Sp1-mediated transcriptional effects involving arylsulfatase B, chondroitin 4-sulfate, and galectin-3.

Bhattacharyya S, Feferman L, Tobacman JK.

J Biol Chem. 2014 Jun 20;289(25):17564-75. doi: 10.1074/jbc.M114.561589. Epub 2014 Apr 28.

20.

Galectin-3 regulates desmoglein-2 and intestinal epithelial intercellular adhesion.

Jiang K, Rankin CR, Nava P, Sumagin R, Kamekura R, Stowell SR, Feng M, Parkos CA, Nusrat A.

J Biol Chem. 2014 Apr 11;289(15):10510-7. doi: 10.1074/jbc.M113.538538. Epub 2014 Feb 24.

Supplemental Content

Loading ...
Support Center